Zevra Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-09-30
Revenue
$4,449
$3,425
$2,895
Gross Profit
-2,232
160
2,751
EBITDA
-22,233
-18,924
-13,626
EBIT
-23,795
-20,486
-13,688
Net Income
-19,925
-16,622
-14,045
Net Change In Cash
4,449
3,425
2,895
Free Cash Flow
-19,109
-16,165
-4,800
Cash
39,260
42,849
43,269
Basic Shares
41,899
41,778
34,724

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$27,461
$10,458
$28,650
$13,288
Gross Profit
24,516
10,115
26,591
11,983
EBITDA
-48,598
-24,082
7,977
-4,692
EBIT
-49,604
-25,026
7,720
-4,965
Net Income
-46,049
-41,543
-8,555
-12,760
Net Change In Cash
27,461
10,458
28,650
13,288
Free Cash Flow
-33,830
-18,810
10,337
-1,972
Cash
43,049
65,466
112,346
4,213
Basic Shares
35,452
34,488
29,766
3,980

Earnings Calls

Quarter EPS
2024-06-30
-$0.48
2024-03-31
-$0.40
2023-12-31
-$0.40
2023-09-30
-$0.40